期刊论文详细信息
BMC Systems Biology
Flux variability scanning based on enforced objective flux for identifying gene amplification targets
Sang Yup Lee1  Tae Yong Kim3  Hyun Uk Kim3  Won Jun Kim2  Hye Min Park2  Jong Myoung Park3 
[1] Department of Bio and Brain Engineering and BioProcess Engineering Research Center, KAIST, Daejeon, 305-701, Republic of Korea;Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, Republic of Korea;BioInformatics Research Center, KAIST, Daejeon, 305-701, Republic of Korea
关键词: Escherichia coli;    Putrescine;    Grouping reaction constraints;    Flux variability scanning based on enforced objective flux;   
Others  :  1143698
DOI  :  10.1186/1752-0509-6-106
 received in 2012-06-19, accepted in 2012-08-15,  发布年份 2012
PDF
【 摘 要 】

Background

In order to reduce time and efforts to develop microbial strains with better capability of producing desired bioproducts, genome-scale metabolic simulations have proven useful in identifying gene knockout and amplification targets. Constraints-based flux analysis has successfully been employed for such simulation, but is limited in its ability to properly describe the complex nature of biological systems. Gene knockout simulations are relatively straightforward to implement, simply by constraining the flux values of the target reaction to zero, but the identification of reliable gene amplification targets is rather difficult. Here, we report a new algorithm which incorporates physiological data into a model to improve the model’s prediction capabilities and to capitalize on the relationships between genes and metabolic fluxes.

Results

We developed an algorithm, flux variability scanning based on enforced objective flux (FVSEOF) with grouping reaction (GR) constraints, in an effort to identify gene amplification targets by considering reactions that co-carry flux values based on physiological omics data via “GR constraints”. This method scans changes in the variabilities of metabolic fluxes in response to an artificially enforced objective flux of product formation. The gene amplification targets predicted using this method were validated by comparing the predicted effects with the previous experimental results obtained for the production of shikimic acid and putrescine in Escherichia coli. Moreover, new gene amplification targets for further enhancing putrescine production were validated through experiments involving the overexpression of each identified targeted gene under condition-controlled batch cultivation.

Conclusions

FVSEOF with GR constraints allows identification of gene amplification targets for metabolic engineering of microbial strains in order to enhance the production of desired bioproducts. The algorithm was validated through the experiments on the enhanced production of putrescine in E. coli, in addition to the comparison with the previously reported experimental data. The FVSEOF strategy with GR constraints will be generally useful for developing industrially important microbial strains having enhanced capabilities of producing chemicals of interest.

【 授权许可】

   
2012 Park et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150329202636480.pdf 2452KB PDF download
Figure 4. 109KB Image download
Figure 3. 104KB Image download
Figure 2. 101KB Image download
Figure 1. 144KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Lee SY, Lee DY, Kim TY: Systems biotechnology for strain improvement. Trends Biotechnol 2005, 23:349-358.
  • [2]Joyce AR, Palsson BO: The model organism as a system: integrating 'omics' data sets. Nat Rev Mol Cell Biol 2006, 7:198-210.
  • [3]Kim HU, Kim TY, Lee SY: Metabolic flux analysis and metabolic engineering of microorganisms. Mol Biosyst 2008, 4:113-120.
  • [4]Kim TY, Sohn SB, Kim YB, Kim WJ, Lee SY: Recent advances in reconstruction and applications of genome-scale metabolic models. Curr Opin Biotechnol 2011, 23:617-623.
  • [5]Lee KH, Park JH, Kim TY, Kim HU, Lee SY: Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol 2007, 3:149.
  • [6]Park JH, Lee KH, Kim TY, Lee SY: Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A 2007, 104:7797-7802.
  • [7]Lee SJ, Lee DY, Kim TY, Kim BH, Lee J, Lee SY: Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation. Appl Environ Microbiol 2005, 71:7880-7887.
  • [8]Bro C, Regenberg B, Forster J, Nielsen J: In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production. Metab Eng 2006, 8:102-111.
  • [9]Yim H, Haselbeck R, Niu W, Pujol-Baxley C, Burgard A, Boldt J, Khandurina J, Trawick JD, Osterhout RE, Stephen R, et al.: Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol 2011, 7:445-452.
  • [10]Jamshidi N, Palsson BO: Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol 2007, 1:26. BioMed Central Full Text
  • [11]Kim HU, Kim TY, Lee SY: Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst 2010, 6:339-348.
  • [12]Kim HU, Kim SY, Jeong H, Kim TY, Kim JJ, Choy HE, Yi KY, Rhee JH, Lee SY: Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol 2011, 7:460.
  • [13]Jensen PR, Hammer K: The sequence of spacers between the consensus sequences modulates the strength of prokaryotic promoters. Appl Environ Microbiol 1998, 64:82-87.
  • [14]Koffas MA, Jung GY, Stephanopoulos G: Engineering metabolism and product formation in Corynebacterium glutamicum by coordinated gene overexpression. Metab Eng 2003, 5:32-41.
  • [15]Delgado J, Liao JC: Inverse flux analysis for reduction of acetate excretion in Escherichia coli. Biotechnol Prog 1997, 13:361-367.
  • [16]Burgard AP, Nikolaev EV, Schilling CH, Maranas CD: Flux coupling analysis of genome-scale metabolic network reconstructions. Genome Res 2004, 14:301-312.
  • [17]Puchalka J, Oberhardt MA, Godinho M, Bielecka A, Regenhardt D, Timmis KN, Papin JA: Martins dos Santos VA: Genome-scale reconstruction and analysis of the Pseudomonas putida KT2440 metabolic network facilitates applications in biotechnology. PLoS Comput Biol 2008, 4:e1000210.
  • [18]Bundy JG, Papp B, Harmston R, Browne RA, Clayson EM, Burton N, Reece RJ, Oliver SG, Brindle KM: Evaluation of predicted network modules in yeast metabolism using NMR-based metabolite profiling. Genome Res 2007, 17:510-519.
  • [19]Khannapho C, Zhao H, Bonde BK, Kierzek AM, Avignone-Rossa CA, Bushell ME: Selection of objective function in genome scale flux balance analysis for process feed development in antibiotic production. Metab Eng 2008, 10:227-233.
  • [20]Bushell ME, Sequeira SI, Khannapho C, Zhao H, Chater KF, Butler MJ, Kierzek AM, Avignone-Rossa CA: The use of genome scale metabolic flux variability analysis for process feed formulation based on an investigation of the effects of the zwf mutation on antibiotic production in Streptomyces coelicolor. Enzyme Microb Technol 2006, 39:1347-1353.
  • [21]Mahadevan R, Schilling CH: The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng 2003, 5:264-276.
  • [22]Pharkya P, Maranas CD: An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. Metab Eng 2006, 8:1-13.
  • [23]Choi HS, Lee SY, Kim TY, Woo HM: In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol 2010, 76:3097-3105.
  • [24]Kim J, Reed JL: OptORF: Optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains. BMC Syst Biol 2010, 4:53. BioMed Central Full Text
  • [25]Lun DS, Rockwell G, Guido NJ, Baym M, Kelner JA, Berger B, Galagan JE, Church GM: Large-scale identification of genetic design strategies using local search. Mol Syst Biol 2009, 5:296.
  • [26]Jung YK, Kim TY, Park SJ, Lee SY: Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers. Biotechnol Bioeng 2010, 105:161-171.
  • [27]Ranganathan S, Suthers PF, Maranas CD: OptForce: an optimization procedure for identifying all genetic manipulations leading to targeted overproductions. PLoS Comp Biol 2010, 6:e1000744.
  • [28]Park JM, Kim TY, Lee SY: Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses. Proc Natl Acad Sci U S A 2010, 107:14931-14936.
  • [29]Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et al.: STRING 8–a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:D412-416.
  • [30]Lee SY, Woo HM, Lee D-Y, Choi HS, Kim TY, Yun H: Systems-level analysis of genome-scale microbial metabolisms under the integrated software environment. Biotechnol Bioproc Eng 2005, 10:425-431.
  • [31]Reed JL, Vo TD, Schilling CH, Palsson BO: An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 2003, 4:R54. BioMed Central Full Text
  • [32]Neidhardt FC, Umbarger HE: Chemical composition of Escherichia coli. In . In Escherichia coli and Salmonella: cellular and molecular biology. 2nd edition. Edited by Neidhardt FC, Curtiss R. ASM Press, Washington, D.C; 1996:13-16.
  • [33]Park JM, Kim TY, Lee SY: Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol Adv 2009, 27:979-988.
  • [34]Qian ZG, Xia XX, Lee SY: Metabolic engineering of Escherichia coli for the production of putrescine: a four carbon diamine. Biotechnol Bioeng 2009, 104:651-662.
  • [35]Lee SY, Chang HN: High cell density cultivation of Escherichia coli W using sucrose as a carbon source. Biotechnol Lett 1993, 15:971-974.
  • [36]Onal A: A review: Current analytical methods for the determination of biogenic amines in foods. Food Chem 2007, 103:1475-1486.
  • [37]Yildirim HK, Uren A, Yucel U: Evaluation of biogenic amines in organic and non-organic wines by HPLC OPA derivatization. Food Technol Biotechnol 2007, 45:62-68.
  • [38]Kramer M, Bongaerts J, Bovenberg R, Kremer S, Muller U, Orf S, Wubbolts M, Raeven L: Metabolic engineering for microbial production of shikimic acid. Metab Eng 2003, 5:277-283.
  • [39]Johansson L, Lindskog A, Silfversparre G, Cimander C, Nielsen KF, Linder G: Shikimic acid production by a modified strain of E. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions. Biotechnol Bioeng 2005, 92:541-552.
  • [40]Knop DR, Draths KM, Chandran SS, Barker JL, von Daeniken R, Weber W, Frost JW: Hydroaromatic equilibration during biosynthesis of shikimic acid. J Am Chem Soc 2001, 123:10173-10182.
  • [41]Knaggs AR: The biosynthesis of shikimate metabolites. Nat Prod Rep 2003, 20:119-136.
  • [42]Chandran SS, Yi J, Draths KM, von Daeniken R, Weber W, Frost JW: Phosphoenolpyruvate availability and the biosynthesis of shikimic acid. Biotechnol Prog 2003, 19:808-814.
  • [43]Escalante A, Calderon R, Valdivia A, de Anda R, Hernandez G, Ramirez OT, Gosset G, Bolivar F: Metabolic engineering for the production of shikimic acid in an evolved Escherichia coli strain lacking the phosphoenolpyruvate: carbohydrate phosphotransferase system. Microb Cell Fact 2010, 9:21. BioMed Central Full Text
  • [44]Lu JL, Liao JC: Metabolic engineering and control analysis for production of aromatics: Role of transaldolase. Biotechnol Bioeng 1997, 53:132-138.
  • [45]Patnaik R, Liao JC: Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl Environ Microbiol 1994, 60:3903-3908.
  • [46]Yi J, Draths KM, Li K, Frost JW: Altered glucose transport and shikimate pathway product yields in E. coli. Biotechnol Prog 2003, 19:1450-1459.
  • [47]Keasling JD: Gene-expression tools for the metabolic engineering of bacteria. Trends Biotechnol 1999, 17:452-460.
  • [48]Thiele I, Jamshidi N, Fleming RM, Palsson BO: Genome-scale reconstruction of Escherichia coli's transcriptional and translational machinery: a knowledge base, its mathematical formulation, and its functional characterization. PLoS Comput Biol 2009, 5:e1000312.
  文献评价指标  
  下载次数:13次 浏览次数:9次